ByRuby is a food delivery company. It sources produce from local ethical suppliers, prepares meals in small batches using the raw produce, freezes the meal to preserve the taste, and delivers it nationwide. ByRuby argues that the UK ready meal sales market is worth £12 billion in 2020. The company witnessed sales up to 200% online in March 2020. ByRuby asserts that it uses only British free-range or organic meat & sustainably sourced fish from British waters. The company won the 2018 Women's Health Food Award. Its products are stocked in 26 retail stores. ByRuby has been mentioned by publications such as Daily Mail, Daily Telegraph, and Metro. It will use 50% of the investment for marketing, 26% to grow its kitchen team, 17% to upgrade its kitchen and 7% for new product development.
days to go:
Expired
investment:
£288,243
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.
days to go:
Expired
investment:
£211,595
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.
days to go:
Expired
investment:
£270,543
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.
days to go:
Expired
investment:
£200,000
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.
days to go:
Expired
investment:
£1,048,396
gowithYamo aims to make art more accessible to everyone, from art newbies to experienced gallery-goers through its application. Users can collect Yamo points by checking-in to galleries and exchanging them for rewards such as art prints and exhibition tickets from the company's in-app store. gowithYamo provides support to galleries, museums and artists by exposing them to an active community of art lovers. The company also offers custom-built virtual exhibition spaces where artists can show and sell their work to a sizeable digital audience. gowithYamo has collaborated with art entities like Roy's Art Fair, The Other Art Fair, Harlesden High Street, and many others. It has a social media presence of 50,000+ followers. The company will use 30% of the investment to expand across different demographics, 25% to further finetune its virtual exhibition platform, 20% for marketing, and 25% to implement Artificial Intelligence (AI) in the gowithYamo app to help recommend exhibitions to its users.
days to go:
Expired
investment:
£161,105
Grocemania is an on-demand delivery platform, which allows customers to find and shop from local grocery stores and receive deliveries in minutes for only £2.50 at absolutely no cost to retailers. The company asserts that its team has been at the forefront of the pandemic delivering everyday essentials to thousands of people across London, Brighton, and Bristol in the UK. Grocemania has helped local retailers to generate £200,000 in sales through its platform since January 2020. It has allowed brands to subscribe and get detailed data analytics and sales insights about their products through its 'Data Reporting' module, and partnered with PepsiCo to maximize PepsiCo, Walkers, and Doritos sales during the UEFA Champions League Group Stage 2020. The company has featured in Timeout, The Grocer, Food Navigator, eMarketer, and UK Technews. It will use the investment to boost marketing and grow its monthly budget by 10 times, test its data module with current partnerships and create useful case-studies to secure more contracts, and invest more in local and product SEO.
days to go:
Expired
investment:
£173,781
Innis & Gunn is a leading craft brewer who is building Edinburgh's biggest brewery. The company has sold 21 million pints of beer in more than thirty countries, and its lager is a leading craft beer in Scotland. It has witnessed a turnover of 21 million in 2018. It is operating in over 30 countries. Innis & Gunn had secured £15m private equity backing in 2017. The proceeds will be used for the construction of large scale brewery which will secure the company's growth capacity and its future in Edinburg.
days to go:
Expired
investment:
£3,300,404
blend my day creates, produces and delivers delicious and nutritionist-approved wholefood breakfasts which can be freshly prepared in under a minute. Its product range consists of an assortment of entities from its ready-to-blend smoothies to ready-to-soak oats bowls. The company's products are 100% plant-based, gluten-free and dairy-free. blend my day argues that the breakfast market is worth £20 billion in the UK and France alone. It wants to become the leading healthy breakfast subscription service in the UK and Europe. The company has sold 20,000 products to date, has an Instagram following of 10,000, and is a part of '1% For the Planet' enterprise pledging to give 1% of all its sales to environmental organisations. blend my day will use the investment to launch a subscription plan to drive repeat purchase and lifetime value, invest in marketing campaigns, build its growth and operations team in the UK, and launch its foodservice range.
days to go:
Expired
investment:
£189,692
Agua de Madre is craft-brewed water kefir aimed at the evergrowing no- and low- alcohol UK market. It aims to be an ethical brand that makes a delicious drink with live bacteria up to 250 billion live cultures per 100ml. The naturally low-alcohol fizzy water kefir is sold in deli's, restaurants, bars, and other food stores in London. Agua de Madre has also attracted media interest from major publications including Metro, Vogue, and Wallpaper. Furthermore, the company is planning to maximise its production potential, hire a specialist sales agency Windfall, expand to sell further in southwest London, and ramp up marketing with its PR Agency, Visible.
days to go:
Expired
investment:
£250,990
